Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5210PDF: 1344HTML: 2757Cover letter: 206 -
The diagnostic pitfalls of mucormycosis
954PDF: 733HTML: 256 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3359PDF: 588HTML: 674 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1484PDF: 918Suppl. Files: 460HTML: 246 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2098PDF: 1063HTML: 15661COVER LETTER: 195 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1013PDF: 372HTML: 208 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3993PDF: 1498HTML: 8522 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3615PDF: 1520HTML: 4438CoverLetter: 189Figure1: 202 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3389PDF: 1164HTML: 449 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2671PDF: 952HTML: 560 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3310PDF: 1562HTML: 455 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
962PDF: 524HTML: 216 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1374PDF: 998HTML: 2008Cover letter: 204 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2555PDF: 956HTML: 306 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4378PDF: 1532HTML: 1562Untitled: 241 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1319PDF: 947HTML: 92 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1234PDF: 932HTML: 292 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2489PDF: 1254HTML: 3611Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 415 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3664PDF: 1124HTML: 23355 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1058PDF: 945Suppl. Files: 598HTML: 94 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1807PDF: 549HTML: 16983Figure 4: 175Figure 3: 145Figure 2: 152Figure 1: 189 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
723PDF: 553HTML: 220 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3735PDF: 1252HTML: 3909Untitled: 234Untitled: 271







